Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Sunil Gairola"'
Autor:
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Anand Kawade, Sanjay Lalwani, M. D. Ravi, Veena Kamath, Jagannath Mahopatra, Ganesh Kulkarni, Deepak Tayade, Padmasani Venkat Ramanan, Kheya Ghosh Uttam, Lalit Rawal, Avinash Gawande, N. Ravi Kumar, Nishikant Tiple, Jayant Vagha, Pareshkumar Thakkar, Prashant Khandgave, Bhaskar Jedhe Deshmukh, Anurag Agarwal, Vikas Dogar, Manish Gautam, K. S. Jaganathan, Rakesh Kumar, Inderjit Sharma, Sunil Gairola
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract A fully liquid hexavalent containing Diphtheria (D), Tetanus (T) toxoids, whole cell Pertussis (wP), Hepatitis B (Hep B), type 1, 2, 3 of inactivated poliovirus (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (DTwP-HepB-IPV-H
Externí odkaz:
https://doaj.org/article/68bd839a94164956a4fbd1e7aac7e457
Autor:
Hitt J Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Anand Kawade, Mandyam Ravi, Jitendra Oswal, Saji James, N. Mahantashetti, Renuka Munshi, Apurba Ghosh, Venkateshwar Rao, Sundaram Balsubramaniam, P. Varughese, A. Somshekhar, Amy Sarah Ginsburg, Harish Rao, Manish Gautam, Sunil Gairola, Umesh Shaligram
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 278-287 (2023)
Background This study assessed safety and immunogenicity of Serum Institute of India Pvt Ltd (SIIPL)’s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster vaccine (Tdap). Research Design and Methods In this Phase II/III, mu
Externí odkaz:
https://doaj.org/article/e0cedde7b1a44c5e8540564550c33c7a
Autor:
Sushant Shengule, Shweta Alai, Sachin Bhandare, Sumant Patil, Manish Gautam, Bhushan Mangaonkar, Sumit Gupta, Umesh Shaligram, Sunil Gairola
Publikováno v:
Vaccines, Vol 12, Iss 4, p 433 (2024)
Antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are multi-targeted and variable over time. Multiplex quantitative serological assays are needed to provide accurate and robust seropositivity data for the establishmen
Externí odkaz:
https://doaj.org/article/05e45cc5dac04f07953ae738d035ca25
Autor:
Hitt Sharma, K. Anil, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, R.L. Madhusudhan, Jaya Patel, Anand Eswaraiah, Harish Rao, Sunil Gairola, Umesh Shaligram
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100313- (2023)
Background: This first in human study was designed as an open label clinical trial to assess safety and tolerability of Serum Institute of India Pvt. Ltd. (SIIPL) quadrivalent HPV (qHPV) vaccine. Methods: A total of 48 healthy male and female (24 eac
Externí odkaz:
https://doaj.org/article/49eb978f4b7342f985c76e613995543d
Autor:
Hitt Sharma, Kiran Marthak, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Akash Patel, Harish Rao, Sunil Gairola, Umesh Shaligram
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100300- (2023)
Background: To assess safety and tolerability of a diphtheria and tetanus toxoid, acellular pertussis, inactivated poliovirus and Haemophilus influenza type B conjugate adsorbed vaccine (DTaP-IPV + Hib), manufactured by Serum Institute of India Pvt.
Externí odkaz:
https://doaj.org/article/c5b54c077f8c4ec3bf22efb094a820ae
Autor:
Vishal Rathod, Laxmikant Kadam, Manish Gautam, Prabhu Dasu Gumma, Kevin Marke, Cathy Asokanathan, Alex Douglas-Bardsley, Laura Hassell, Sachin Bhandare, Sumit Gupta, Sameer Parekh, Pramod Pujari, Harish Rao, Hitt Sharma, Umesh Shaligram, Sunil Gairola
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundLuminex bead-based assays offer multiplexing to test antibodies against multiple antigens simultaneously; however, this requires validation using internationally certified reference standards. Therefore, there is an urgent need to character
Externí odkaz:
https://doaj.org/article/f818b55648204f84bf22b0d1516e44ee
Autor:
Gaurav Nagar, Siddharth Jain, Meghraj Rajurkar, Rakesh Lothe, Harish Rao, Sourav Majumdar, Manish Gautam, Sergio A. Rodriguez-Aponte, Laura E. Crowell, J. Christopher Love, Prajakta Dandekar, Amita Puranik, Sunil Gairola, Umesh Shaligram, Ratnesh Jain
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1602 (2023)
SARS-CoV-2 spike protein is an essential component of numerous protein-based vaccines for COVID-19. The receptor-binding domain of this spike protein is a promising antigen with ease of expression in microbial hosts and scalability at comparatively l
Externí odkaz:
https://doaj.org/article/803238a4a29446febff56c33b9a18df2
Autor:
Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale, Sonali Palkar, Neeta Hanumante, Shilpa Gokhale, Jaganathan Ks, Rakesh Kumar, Inderjit Sharma, Sunil Gairola
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
This first in human study was designed as an open label clinical trial to assess the safety and immunogenicity of SIIPL DTwP-HepB-IPV-Hib (Hexavalent) combination vaccine in healthy toddlers, aged 16–24 months. A total of 24 healthy toddlers were a
Externí odkaz:
https://doaj.org/article/cdd376e1788d4b8c9561126652699c3f
Autor:
Akash Saggam, Prathamesh Kale, Sushant Shengule, Dada Patil, Manish Gautam, Girish Tillu, Kalpana Joshi, Sunil Gairola, Bhushan Patwardhan
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Chemotherapy-induced myelosuppression is one of the major challenges in cancer treatment. Ayurveda-based immunomodulatory botanicals Asparagus racemosus Willd (AR/Shatavari) and Withania somnifera (L.). Dunal (WS/Ashwagandha) have potential role to m
Externí odkaz:
https://doaj.org/article/7ec84c63df7343c9b55919a146e92b4a
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 8, Pp 1857-1865 (2020)
Global efforts on the replacement of the in vivo rabies vaccine potency test (NIH method) with in vitro methods for quantification of immunodominant glycoprotein (GP) in rabies vaccine have made significant progress. We report here, a sandwich ELISA
Externí odkaz:
https://doaj.org/article/9124d1b103d448be99c1ab9ad4d3b87c